Delivery Order SPE2DB24D2205-SPE2DB24FDWHX

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,194.38, is for the delivery of FLAREX 0.1% eye drops (5 ml) to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $1,646.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLAREX 0.1% eye drops, a pharmaceutical product, with a completion date of February 6, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,127.91 firm fixed-price delivery order is for FLAREX 0.1% eye drops, a pharmaceutical product. The contract has a period of performance through June 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of FLAREX 0.1% eye drops in 5 milliliter vials. The contract has a firm fixed price of $4,650.00 and a completion date of August 30, 2024. No set-aside was used for this award. AmerisourceBergen, through its corporate office division, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,375.32, is for the delivery of FLAREX 0.1% eye drops in 5ml containers. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 21, 2023. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract...
This federal contract award, valued at $4,468.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of FLAREX 0.1% eye drops (5ml) and has an ultimate completion date of June 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,821.70 delivery order covers the procurement of FLAREX 0.1% eye drops, a specialty ophthalmic medication, with a completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FLAREX 0.1% eye drops. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,878.33 and an ultimate completion date of June 18, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,838.84 firm fixed-price delivery order is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product used for ophthalmic treatment. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen is the prime contractor and there are no set-aside requirements indicated. The company...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $13,170.83 for FLAREX 0.1% eye drops. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDWHX
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $4,431.11, is for the delivery of FLAREX 0.1% eye drops in 5ml containers.

The award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, through its Corporate Office Division, leverages its parent company's extensive supply chain network to efficiently fulfill government contracts for critical medical products.

Generated 10/1/24, 9:42 AM